US2023241393A1PendingUtilityA1

Stimulator systems and methods for obstructive sleep apnea

Assignee: THE ALFRED E MANN FOUNDATION FOR SCIENT RESEARCHPriority: Feb 1, 2017Filed: Apr 6, 2023Published: Aug 3, 2023
Est. expiryFeb 1, 2037(~10.5 yrs left)· nominal 20-yr term from priority
A61N 1/3611A61N 1/3601A61B 1/267A61B 5/0836A61B 5/0878A61N 1/0556A61N 1/36139A61N 1/3787A61B 5/4818A61N 1/37211A61B 5/4836A61B 5/394A61B 2562/0219
78
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

An electrode lead comprises an electrically insulative cuff body and at least three axially aligned electrode contacts circumferentially disposed along the inner surface of the cuff body when in the furled state. The electrode contacts may be circumferentially disposed around a nerve, and an electrical pulse train may be delivered to the electrode contacts thereby stimulating the nerve to treat obstructive sleep apnea. The electrical pulse train may be one that pre-conditions peripherally located nerve fascicles to not be stimulated, while stimulating centrally located nerve fascicles. A feedback mechanism can be used to titrate electrode contacts and electrical pulse train to the patient. A sensor that is affixed to the case of a neurostimulator can be used to measure physiological artifacts of respiration, and a motion detector can be used to sense tapping of the neurostimulator to toggle the neurostimulator between an ON position and an OFF position.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A neurostimulation system for treating obstructive sleep apnea (OSA) in a patient, comprising:
 an electrode lead carrying at least one electrode contact;   a neurostimulator configured for delivering an electrical pulse train to the at least one electrode contact;   an oral appliance coupled wirelessly to the neurostimulator the oral appliance configured for measuring a physiological parameter of the patient indicative of an efficacy of the delivered electrical pulse train in treating the OSA.   
     
     
         2 . The neurostimulation system of  claim 1 , wherein the neurostimulator is further configured for:
 sensing physiological artifacts that are caused by respiration, and   delivering the electrical pulse train to the at least one electrode contact in synchronization with a respiratory cycle based on the sensed physiological artifacts.   
     
     
         3 . The neurostimulation system of  claim 2 , wherein the neurostimulator is configured for:
 determining the next projected onset of an inspiratory phase of the respiratory cycle based on the sensed physiological artifacts, and   delivering the electrical pulse train to the at least one electrode contact immediately before, at, or right after the next projected onset of the inspiratory phase of the respiratory cycle.   
     
     
         4 . The neurostimulation system of  claim 2 , wherein the neurostimulator is configured for storing data representative of the physiological artifacts sensed by the sensing circuitry. 
     
     
         5 . The neurostimulation system of  claim 1 , wherein the electrical pulse train has an initial, preconditioning current or voltage amplitude and a subsequent higher stimulating current or voltage amplitude. 
     
     
         6 . The neurostimulation system of  claim 1 , further comprising a clinician programmer configured for:
 selecting the at least one electrode contact from a plurality of electrode contacts, and transcutaneously communicating with the neurostimulator, and   programming the neurostimulator to deliver the electrical pulse train to the selected at least one electrode contact.   
     
     
         7 . The neurostimulation system of  claim 1 , further comprising a patient programmer configured for:
 transcutaneously communicating with the neurostimulator, and   toggling the neurostimulator between an OFF position and an ON position, such that in the OFF position, no stimulation is delivered to the at least one electrode contact.   
     
     
         8 . The neurostimulation system of  claim 1 , further comprising an external charger configured for inductively and transcutaneously charging the neurostimulator. 
     
     
         9 . The neurostimulation system of  claim 1 , further comprising a clinician programmer configured for computing a therapy score of the at least one electrode based on the measured physiological parameter. 
     
     
         10 . The neurostimulation system of  claim 9 , wherein the clinician programmer is configured for:
 determining the efficiency of each inspiration phase in the respiratory cycle based on the measured physiological parameter, and   computing the therapy score based on the determined efficiency of each inspiration phase in the respiratory cycle.   
     
     
         11 . The neurostimulation system of  claim 9 , wherein the oral appliance comprises one or more inertial sensors, the measured physiological parameter is the movement of the tongue of the patient, and the clinician programmer is configured for determining the extent to which the tongue of the patient protrudes based on the measured physiological parameter, and computing the therapy score based on the determined extent to which the tongue of the patient protrudes. 
     
     
         12 . The neurostimulation system of  claim 1 , wherein the oral appliance comprises one or more inertial sensors, wherein the one or more inertial sensors measure the movement of the tongue in response to electrical stimulation of a hypoglossal nerve. 
     
     
         13 . The neurostimulator of  claim 12 , wherein the one or more inertial sensors comprise at least one of an accelerometer and a gyroscope. 
     
     
         14 . The neurostimulator of  claim 12 , further comprising a clinician programmer coupled wirelessly to the oral appliance and/or to the neurostimulator, the clinician programmer configured for computing a therapy score based on signals output by the inertial sensor. 
     
     
         15 . The neurostimulator of  claim 1 , wherein the oral appliance comprises at least one electromyographic (EMG) sensor configured for measuring the physiological parameter, the physiological parameter comprising an electrical potential generated by the muscle cells of the tongue in response to electrical stimulation of a hypoglossal nerve. 
     
     
         16 . The neurostimulator of  claim 15 , further comprising a clinician programmer coupled wirelessly to the oral appliance and/or to the neurostimulator, the clinician programmer configured to compute a therapy score based on signals output by the electromyographic sensor.

Join the waitlist — get patent alerts

Track US2023241393A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.